Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need of urgent attention.
Alcidion's Patientrack system will help staff intervene early to prevent harm when patients show signs of worsening conditions.
Moderna (Nasdaq: MRNA) and IBM (NYSE: IBM) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central to the effort will be a pilot of open, standardized, technology-enabled vaccine distribution approaches aimed to improve supply chain visibility and foster near real-time tracking of vaccine administration.
Elsevier, together with Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier and others, has further refined and extended its drug-drug interaction risk calculator (DDIRC) within PharmaPendium. The DDIRC 2.0 aims to help scientists improve patient safety and effectively manage drug-drug interaction (DDI) risks across the drug development process.
The Elisabeth-TweeSteden Hospital (ETZ) based in Tilburg and Waalwijk in the Netherlands is adopting a new digital training platform. It helps clinical staff optimize the use of its electronic patient dossier (EPD) system, Epic®. The healthcare organization is rolling out ANCILE Solutions’ uPerform platform after successful completion of an initial project in 2020.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based openDoctor announced a partnership to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of Philips' newly launched Patient Management Solution.
Abbott (NYSE: ABT) announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed. Approved by the U.S. Food and Drug Administration, the NeuroSphere Virtual Clinic has the potential to